REG - Treatt PLC - Notification of Transactions of a PCA

TreattAnnouncement

14/07/2021 16:20

RNS Number : 2708F
  
Treatt PLC
  
14 July 2021
  
 

 
14 July 2021
TREATT PLC
("Treatt" or "the Company")
Notification of Transactions of a Person Closely Associated (PCA)
The Company was notified on 14 July 2021 that a PCA (Person Closely Associated with a PDMR) sold a total of 4,705 ordinary shares of the Company at a weighted average price of £10.95 per ordinary share, details of which are below.
The information contained in this notification is disclosed in accordance with the requirements of the EU Market Abuse Regulation.



1


Details of the Person Closely Associated (PCA)




a)


Name


Tracey Smith




2


Reason for the notification




a)


Position/status


PCA to Richard Hope, Chief Financial Officer




b)


Initial notification/Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


 Treatt Plc




b)


LEI


 213800G40JM9F7G9LG39




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)
 


Description of the financial instrument, type of instrument
Identification code


Ordinary share of 2 pence each
 
 
GB00BKS7YK08




b)


Nature of transaction


Sale of ordinary shares




c)


Price(s) and volume(s)


Price(s)


Volume(s)












£10.96
£10.955
£10.929
£10.90
£10.9822


1,000
1,000
1,000
1,000
   705








Aggregated information
-      Aggregated volume
-      Price 


 
4,705
£10.95




e)


Date of the transaction


14 July 2021




f)


Place of the transaction


London Stock Exchange, XLON



 
Contact details
Anita Guernari
Company Secretary
++ 44 1284 770028
END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHGPUBUMUPGGAC